4.30
price up icon3.12%   0.13
pre-market  Pre-mercato:  4.37   0.07   +1.63%
loading

Abcellera Biologics Inc Azioni (ABCL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
303.40%
17.08
4.235 6.507 7.323 9.954
Operating Expenses
0.34%
66.67
66.89 100.17 100.78 64.85
Benefits Costs and Expenses
6.63%
53.43
57.22 69.14 55.51 52.70
Costs And Expenses
6.63%
53.43
57.22 69.14 55.51 52.70
Depreciation and Amortization
2.61%
5.47
5.331 - - 4.844
Operating Income/Loss
20.87%
-49.59
-62.66 -93.66 -93.45 -54.89
Nonoperating Income/Loss
36.84%
13.24
9.676 31.03 45.27 12.15
Income/Loss From Continuing Operations Before Tax
31.41%
-36.34
-52.98 -62.63 -48.19 -42.75
Income Tax Expense/Benefit
78.04%
-1.617
-7.363 -11.53 -11.26 -2.137
Income/Loss From Continuing Operations After Tax
23.88%
-34.73
-45.62 -51.11 -36.93 -40.61
Net Income/Loss
23.88%
-34.73
-45.62 -51.11 -36.93 -40.61
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.27%
298.51
297.69 294.85 294.22 292.72
Diluted Average Shares
0.27%
298.51
297.69 294.85 294.22 292.72
Basic Earnings Per Share
20.00%
-0.12
-0.15 -0.17 -0.13 -0.14
Diluted Earnings Per Share
20.00%
-0.12
-0.15 -0.17 -0.13 -0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.31
price down icon 1.55%
$86.53
price up icon 0.38%
$26.01
price up icon 0.54%
$110.77
price down icon 0.48%
$132.60
price up icon 2.43%
biotechnology ONC
$313.97
price up icon 1.50%
Capitalizzazione:     |  Volume (24 ore):